These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4745280)

  • 21. Cardiopulmonary effects of progestational agents in emphysematous rats.
    Ino T; Aviado DM
    Chest; 1971 Jun; 59(6):659-66. PubMed ID: 5087936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Anovlar in gynaecological disorders and contraception.
    Shahani SM; Chiklikar A
    J Obstet Gynaecol India; 1968 Apr; 18(2):592-7. PubMed ID: 12331827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of beneficial response of serum GH in acromegalic patients treated with medroxyprogesterone acetate (MPA).
    Jackson IM; Ormston BJ
    J Clin Endocrinol Metab; 1972 Sep; 35(3):413-5. PubMed ID: 5051364
    [No Abstract]   [Full Text] [Related]  

  • 24. Problems in evaluating chronic toxicity of contraceptive steroids in dogs.
    Weikel JH; Nelson LW
    J Toxicol Environ Health; 1977 Sep; 3(1-2):167-77. PubMed ID: 72828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some observations on the changes in capillary resistance in oral contraceptive users.
    Zaki K; Younis MN; Razek SA; Mekkawi TE; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):145-51. PubMed ID: 12256025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medroxyprogesterone acetate and homozygous sickle-cell disease.
    De Ceulaer K; Gruber C; Hayes R; Serjeant GR
    Lancet; 1982 Jul; 2(8292):229-31. PubMed ID: 6178915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo metabolism of H3-medroxyprogesterone acetate in pregnant and nonpregnant women and in the fetus.
    Besch PK; Vorys N; Ullery JC; Barry RD; Couri D
    Am J Obstet Gynecol; 1966 May; 95(2):228-38. PubMed ID: 5935708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral contraceptives and plasma lipids.
    Dhillon MK; Sarkar AK; Gupta AN; Devi PK
    J Obstet Gynaecol India; 1972; 22(6):622-6. PubMed ID: 12332899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pill-a-month as an oral contraceptive.
    Hefnawi F; Hassanein M; Younis N
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
    Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
    J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroid excretion in users of the injectable combined oestrogen progestogen preparation, deladroxate.
    Zaki K; Younis N; Nour H
    Egypt Popul Fam Plann Rev; 1971 Dec; 4(2):1-5. PubMed ID: 12255961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of cyclopia.
    Batts JA; Punnett HH; Valdes-Dapena M; Coles JW; Green WR
    Am J Obstet Gynecol; 1972 Mar; 112(5):657-61. PubMed ID: 5059596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. After-effect of injection.
    Janssens LA
    Vet Rec; 1977 Jan; 100(2):35. PubMed ID: 836606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variable response of plasma GH in acromegalic patients treated with medroxyprogesterone acetate.
    Malarkey WB; Daughaday WH
    J Clin Endocrinol; 1971 Sep; 33():424-31. PubMed ID: 12256545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA.
    Ortiz A; Hirol M; Stanczyk FZ; Goebelsmann U; Mishell DR
    J Clin Endocrinol Metab; 1977 Jan; 44(1):32-8. PubMed ID: 833262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of medroxyprogesterone acetate (MPA) on the blood level of STH in 12 patients with acromegaly].
    Liuzzi A; Chiodini PG; Botalla L; Silvestrini F
    Ann Endocrinol (Paris); 1972; 33(4):426-30. PubMed ID: 4664003
    [No Abstract]   [Full Text] [Related]  

  • 39. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.
    Glasier A; Thong KJ; Dewar M; Mackie M; Baird DT
    N Engl J Med; 1992 Oct; 327(15):1041-4. PubMed ID: 1522839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.